712 related articles for article (PubMed ID: 2177207)
21. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome.
Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 Dec; 41(6):795-800. PubMed ID: 7889616
[TBL] [Abstract][Full Text] [Related]
23. [Cushing's syndrome: diagnostic exploration].
Tabarin A; Roger P
Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of diagnostic tests for ACTH-dependent Cushing's syndrome.
Suda T; Kageyama K; Nigawara T; Sakihara S
Endocr J; 2009; 56(3):469-76. PubMed ID: 19225213
[TBL] [Abstract][Full Text] [Related]
25. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
[TBL] [Abstract][Full Text] [Related]
26. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
[TBL] [Abstract][Full Text] [Related]
27. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
Chen K; Chen S; Lu L; Zhu H; Zhang X; Tong A; Pan H; Wang R; Lu Z
Front Endocrinol (Lausanne); 2021; 12():720823. PubMed ID: 34539574
[TBL] [Abstract][Full Text] [Related]
28. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
[TBL] [Abstract][Full Text] [Related]
29. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
30. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor.
Malchoff CD; Orth DN; Abboud C; Carney JA; Pairolero PC; Carey RM
Am J Med; 1988 Apr; 84(4):760-4. PubMed ID: 2840823
[TBL] [Abstract][Full Text] [Related]
31. Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS:a case report.
Tan H; Chen D; Yu Y; Yu K; He W; Cai B; Jiang S; Tang Y; Tong N; An Z
BMC Endocr Disord; 2020 Jul; 20(1):116. PubMed ID: 32736557
[TBL] [Abstract][Full Text] [Related]
32. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.
Arnaldi G; Tirabassi G; Papa R; Furlani G; Trementino L; Cardinaletti M; Faloia E; Boscaro M
Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661
[TBL] [Abstract][Full Text] [Related]
33. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
[TBL] [Abstract][Full Text] [Related]
34. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
[TBL] [Abstract][Full Text] [Related]
35. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
Findling JW; Kehoe ME; Shaker JL; Raff H
J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
[TBL] [Abstract][Full Text] [Related]
36. Hypothalamic abnormalities in patients with pituitary-dependent Cushing's syndrome.
Stewart PM; Penn R; Gibson R; Holder R; Parton A; Ratcliffe JG; London DR
Clin Endocrinol (Oxf); 1992 May; 36(5):453-8. PubMed ID: 1319858
[TBL] [Abstract][Full Text] [Related]
37. [ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)].
Suzuki S
Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):828-44. PubMed ID: 190054
[TBL] [Abstract][Full Text] [Related]
38. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
Montwill J; Igoe D; McKenna TJ
Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
[TBL] [Abstract][Full Text] [Related]
40. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.
Vilar L; Freitas MC; Naves LA; Canadas V; Albuquerque JL; Botelho CA; Egito CS; Arruda MJ; Silva LM; Arahata CM; Agra R; Lima LH; Azevedo M; Casulari LA
J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
